STA
ATEX icon

Summit Trail Advisors’s Anterix ATEX Stock Holding History

Summit Trail Advisors’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13
Closed – – 520
2017
Q4 		$0 Buy
+13
New +$418 ﹤0.01% 1973

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Summit Trail Advisors's ATEX Position: Q1 2018 in Review

Summit Trail Advisors sold out of Anterix (ATEX) in Q1 2018, closing a stake of 13 shares.

Summit Trail Advisors first reported a position in ATEX in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 51 funds tracked by Wall St. Rank hold ATEX as of Q1 2018.

  • Summit Trail Advisors reported no remaining Anterix position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 13 Anterix shares in Q1 2018.
  • Summit Trail Advisors first reported a position in Anterix in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's Anterix position peaked at $0 in Q4 2017.
  • 51 funds tracked by Wall St. Rank held Anterix as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.